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Gene Mutations: One of the Many Roads to Deafness 
 
Shaun Davis*, Laura Hoholik*, Kushal Modi*, 
Lindsey Rockwell* 
Department of Biology 
Lake Forest College 
Lake Forest, Illinois 60045 
 
Summary 
 
Deafness, a pathological condition causing partial 
or complete loss of hearing, affects nearly 70 
million people worldwide.  Research has linked 
nonsyndromic deafness to over 30 genes.  In this 
review, implications of mutations on four of these 
genes will be discussed to understand how normal 
function is altered.  While various mutations are 
linked to deafness, little is known about the 
mechanisms that lead to deafness.  MyosinVI 
mutations hinder the motor protein’s progressive 
movement, rendering the protein unable to stabilize 
stereocilia.  Point mutations in PMCA2 gene in 
outer hair cells (OHCs) cause a defect in the 
calcium pump, leading to a change in calcium 
concentration in the cell and loss of hearing and 
imbalance.  Mutations on the KCNQ4 gene in the 
OHCs cause K+ channel malfunction, ceasing the 
removal of K+ and inhibiting repolarization, thus 
leading to degeneration of the cell.  Connexin 26 
mutations lead to destruction and degradation of 
critical components within the inner ear, as well as 
problems with gap junction communication.  These 
mutations cause autosomal recessive deafness.  
Currently, there is no cure for deafness, but 
development of treatments such as cochlear 
implants and other electrical systems can improve 
the quality of hearing. Identification and a deeper 
understanding of new genetic mutations can 
enhance treatments. 
 
Introduction 
 
Hearing disorders are the most frequently inherited 
sensory defect in humans, with nearly 70 million people 
across the globe suffering from a form of hearing loss 
(Wilson, 1985).  Hearing disorders may be present at 
birth or occur gradually over a person’s lifetime.  
Deafness, characterized as hearing loss, can be 
environmentally induced, syndromic, or nonsyndromic.  
Damage to the outer or middle ear by exterior sources 
can lead to environmentally induced deafness.   
Syndromic deafness occurs in conjunction with other 
abnormalities unrelated to audition.  This form can be 
dominant, recessive, x-linked, or mitochondrial.  In 
contrast, nonsyndromic deafness occurs without 
recognizable symptoms and can be x-linked, dominant, 
or recessive (Schrijver, 2004).  This review focuses on 
autosomal dominant and recessive forms of 
nonsyndromic deafness.   
Mutations in over 30 genes, many of which 
correspond to processes and development of the inner 
ear, have been related to nonsyndromic deafness. 
Mutations on genes associated with deafness cause a 
variety of defects in the processing of sound.  
____________________________________________ 
 
*These authors wrote the paper for Biology 221: Cell and Molecular 
Biology, taught by Dr. Shubhik K. DebBurman.  
Symptoms of deafness include hearing difficulties and 
ringing in the ears.  However, in children, hearing 
impairment may be difficult to diagnose.  Failure to 
respond to sounds, disinterest in music, and lack of 
verbalization are noticeable signs that can help lead to 
diagnosis (Piatto, 2005).  Children should be screened 
for hearing loss so that deafness can be detected as 
early as possible.   
Hearing loss treatment for children and adults 
has evolved over the years.  Historically, treatments 
used were devoid of any biological bases such as 
inserting a stick into the ear until hearing returned 
(Musiek, 2006).  These treatments have been replaced 
by newer methods, including cochlear implants. Doctors 
place these implants into a patient’s ears through a 
surgical procedure involving an external microphone 
that is connected to an internal electrode placed on the 
auditory nerve.  This produces hearing sensations 
similar to those produced from normal auditory cells 
(Moser, 2006).  Digital hearing aids are another 
treatment available for patients suffering from milder 
cases of hearing impairment.  These hearing aids 
receive sound through a microphone and convert it to 
electrical signals in the device.  The signals are 
intensified by an amplifier, which sends the sound to 
the ear via the speaker. Furthermore, personal 
frequency modulation systems can be used to improve 
hearing quality.  These are comprised of a speaker 
used by an  orator and a receiver used by the listener 
(Carmen, 2004).  Sound is amplified for the listener and 
improves the quality of hearing. 
The work of Georg von Békésy played a 
critical role in the development of the biological model 
of the ear and also in understanding the workings of the 
inner ear.  By 1928, he had developed anatomical 
techniques that allowed for quick, non-damaging 
dissection of the cochlea.  In the 1930’s, he 
demonstrated that the basilar membrane of the cochlea 
has frequency selective properties (Bekesy, 1989).  
While many of his experimental conclusions have since 
been challenged, his pioneering efforts led to further 
knowledge and development in the auditory field. 
In the late 1970s, David Kemp expanded on 
Békésy’s work and discovered otoacoustic emissions, 
which are low intensity sounds produced by the cochlea 
in response to stimuli (Kemp, 2000).  These findings led 
him to develop hearing tests for infants by monitoring 
the levels of these emissions.  More recently, studies 
have focused on identification of the genes responsible 
for inner ear function and development (Heller, 2002).  
This research concluded that mutations interrupt the 
auditory pathway.  Detailed examination of mutations 
occurring on genes linked with deafness will provide a 
more complete picture of how hearing loss occurs.   
Among the many genes that contribute to 
deafness, four specific genes are targeted in this 
review.  While it has long been known that the genes 
studied affect many of the biological workings within the 
cell, they have only recently been linked to deafness 
(Morton, 2002).  Advancements in research for these 
four genes have led to a better understanding of the 
mechanisms functioning in the auditory system.  In this 
study, we will examine these four genes due to their 
essentiality in normal hearing.  
   Exploration of four genes involved in 
nonsyndromic deafness reveals the impact of gene 
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mutations on the auditory system function.  After 
moving through the outer and middle ear, sound waves 
enter the cochlea, causing the tectorial membrane to 
vibrate (Musiek, 2006).  This movement is picked up in 
the hair cells’ stereocilia, where the cell will later 
convert it to chemical signaling.  One of the most critical 
genes involved with stereocilia is Myosin VI, which is 
essential for their maintainance and stabilization.  
 
Myosin VI  
 
An Experienced Traveler 
Myosin VI, a motor protein, is found on the inner and 
outer hair cells of the cochlea.  It is especially 
concentrated in the cuticular plates and pericuticular 
necklace, which is present in the hair cell cytoplasm 
(Figure 1).  Myosin VI is also located at the base of 
microvilli, which is made up of bundles of actin 
filaments. The location of Myosin VI is critical to the 
function of protein in stability of hair cell stereocilia 
(Self, et al., 1999). 
 
Shifting Gears: Putting it in Reverse 
Myosin VI is a very unconventional motor protein 
because it has a domain that binds an actin filament 
with two different ends.  The barbed end of the filament 
is attached to the plasma membrane of a cell and is 
positively charged.  The pointed end is negatively 
charged and reaches towards the inside of the cell 
(Ahmed, 2003).  Typically, proteins of the myosin family 
move towards the positive end of the actin filament, but 
the unconventional Myosin VI moves towards the 
negative end (Hasson, 2003).  This orientation enables 
the protein to transport away from the cell membrane, 
down the microvilli, and towards the cell.  
 
Road Trip: The Mobility Mechanism  
This method of mobility uses a specific mechanism.  
The protein produces movement on each particular 
filament by hydrolyzing ATP.  In this process, ATP 
binds to Myosin VI, hydrolysis occurs, and previously 
bound ATP molecules are released as ADP and 
phosphate, providing the energy needed for movement.  
This hydrolysis reaction allows the protein to move the 
lever arm along the filament towards the negatively 
polarized end (Hasson, 2003). 
 
Jamming on the Breaks: Restricted Movement 
Recently, this movement was found to be essential for 
stabilization and organization of the hair cell stereocilia.  
At birth, wild type mice have normal organization of 
microvilli on the hair cells of the ear.  Each hair cell has 
many differentiated microvilli protruding from the cell.  
Eventually, these microvilli develop into stereocilia 
bundles, which also appear as fingerlike projections 
from the hair cell and aid hair cell function (Hasson, 
2003).    
 
Traffic Jam: Stereocilia Fusion 
Mutant mice are also born with mostly organized 
microvilli that undgo the transition to stereocilia.  
However, as development occurs, disorganization of 
the hair cells begins to increase. By three days after 
birth (DAB), most of the hair cells are affected by the 
process of fusion and excess growth of stereocilia.  As 
stereocilia fuse together, the once differentiated 
stereocilia are reduced to only a few large protrusions 
from the hair cell (Figure 1B).  By 20 DAB, there were 
no hair cells with normal stereocilia remaining in the 
cochlear duct.  These cells fused together to create a 
large mass (Hasson, 2003).  Research determined that 
mice lacking Myosin VI had fused stereocilia and did 
not respond to sound stimuli.  This led to a further 
exploration of the role of Myosin VI in the auditory 
system. 
 Myosin VI is essential for maintenance of the 
stereocilia structures located on the apical surface of 
the hair cells.  This function is specific to Myosin VI, as 
mutations in other myosin proteins do not yield the 
same results (Hasson, 2003).  The area of focus was 
centered on the stabilization of the stereocilia, because 
these cells are where the initial defect occurs in 
organisms with mutated Myosin VI genes.  More 
specifically, the interaction of Myosin VI with the heavy 
concentration of actin at the apical region is significant 
(Hasson, 2003). 
Myosin VI uses its two ends to complete 
different functions.  The tail domain attaches to the 
apical membranes found between the stereocilia, while 
the motor domain anchors this membrane-stereocilia 
structure to the actin in the cuticular plate.  When 
Myosin VI is absent, the apical membrane is poorly 
anchored and rises up in response to surface tension 
among the cells.  This causes the stereocilia to zip up 
until there is no differentiation remaining (Self, 1999). 
At the molecular level, mutations hinder the progressive 
movement of Myosin VI and lead to human autosomal 
dominant deafness.  For example, a missense mutation 
of Cys
442
 to Tyr in the Myosin VI gene alters the ATP 
hydrolysis mechanism and the motor functions of the 
protein.  Previously, the ADP dissociation rate was 
thought to be the limiting factor in the hydrolysis 
reaction, which then limited the amount of movement 
possible for Myosin VI.  More recently, however, it was 
determined that the protein moves great distances 
without dissociating; therefore, ADP dissociation is not 
the rate limiting step.  Additionally, ADP dissociation is 
increased by the mutation of Cys
442
, further supporting 
these latest findings.  The rate limiting step was actually 
determined as the conversion of ATP to ADP and 
phosphate.  The limiting factor of the Myosin VI protein 
that occurs in mutated organisms makes it useless for 
anchoring the membrane and transporting cargo (Sato, 
2004).  The ability of the Myosin VI gene to complete its 
function of stabilizing the stereocilia of the hair cells is 
hindered (Figure 2).  Evidence shows that mutants had 
no stimulus-related cochlear response even at very 
high sound intensities, which is considered profound 
hearing impairment (Self, 1999). 
 
Put It in Park: The Anchor Mechanism 
In mutants, the microvilli must have another anchoring 
mechanism that is sufficient for early development, but 
cannot prevent membrane fusion after they have 
become stereocilia.  It is critical for the microvilli to be 
present in organisms during early development, as they 
are essential for the function of many organs (Self, 
1999).  Eventual loss of stereocilia has less impact than 
complete lack of microvilli, thus enabling the mutants to 
survive, providing they initially possess microvilli. 
 
Where Do We Go From Here? 
Myosin VI is a motor protein that anchors and stabilizes 
the stereocilia.  When functioning normally, Myosin VI 
prevents fusion of the stereocilia, allowing 
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Figure 1. Gene Location in the Inner Ear. In the center of the figure is a diagram of the inner ear.  Radiating from the various locations 
within the inner ear are the four genes covered in this review.  In the four corners are illustrations of the four genes and their functions.
 
them to open the membrane channels and enacting an 
action potential.  As the potential moves down the cell, 
Ca
2+
 must enter to release the chemical signal.  The 
PMCA2 gene plays a critical role in the formation and 
function of the Ca
2+
 channels. 
 
PMCA2 
 
Go With the Flow: Ion Trafficking 
The influx of Ca
2+
 ions is necessary for vesicles to bind 
to the presynaptic membrane and neurotransmitters to 
be released.  The surge of calcium ions is controlled by 
the plasma membrane Ca
2+
 PMCA (ATPase), a 
transport protein in the plasma membrane of cells that 
brings calcium into the cell.  There are four basic 
isoforms of PMCA pump:  PMCA1, PMCA2, PMCA3 
and PMCA4 (Grati et al, 2006).   PMCA1 and PMCA4 
are expressed in many different tissues and cell types, 
whereas PMCA2 (also known as ATP2b2) and PMCA3 
operate in specialized tissues, such as brain and 
muscle tissues (Grati et al, 2006).  PMCA2 
demonstrates a highly restricted tissue distribution, 
suggesting that PMCA2 serves a more specialized and 
physiological function than the other isoforms.       
 Specifically, PMCA2 is thought to be present 
in high levels on the cell membrane of the outer hair 
cells (OHC). PMCA2 plays an essential role for hearing 
in relation to its function in both the vestibular and 
auditory systems.  The main function of the PMCA2 
protein is to bring Ca
2+
 ions into the cell.  Thus, a 
mutation in this protein could cause a Ca
2+
 shortage in 
the cell, which would disable the vesicles from binding 
to the presynaptic membrane and would cause a 
significant loss of hearing (Figure 1C).   
  
Mutation: Takes Its Toll  
A point mutation in the PMCA2 gene, in which adenine 
is substituted with guanine, causes a glycine-to-serine 
substitution (Street et al, 1998). In mice that have this  
 
missense mutation, PMCA2 is no longer localized in the 
stereocilia and the basolateral membrane of hair cells, 
as normally seen in wild-type mice.  This indicates that 
a glycine-to-serine substitution on the PMCA2 protein 
may cause deafness and imbalance (Street et al, 
1998).   
 The particular role of PMCA2 in hearing was 
examined by observing PMCA2 deficient mice.  At five 
weeks of age, these mice demonstrated imbalance of 
movement (Kozel et al, 1998).  They also showed an 
underdevelopment of the organ of Corti canal, as well 
as the hair and the pillar cells (Kozel et al, 1998). This 
suggests that a PMCA2 deficiency is connected to 
structural changes in the organ of Corti tunnel (Figure 
2).  
Additionally, the PMCA2 deficient mice were 
examined by an Auditory Brainstem Response (ABR) 
test, which demonstrated that the PMCA2 deficient 
mice showed no response to varying intensities of 
sound (Kozel et al, 1998).  However, the wild-type mice 
demonstrated a normal response to varying intensities 
of sound (Kozel et al, 1998). This indicates that a lack 
of PMCA2 causes severe imbalance as well as a 
significant loss of hearing.         
Lastly, the effects of ablation on the pump 
were examined.  There are two locations at which the 
ablations could occur, site A and site C.  Site A is 
located in the cytosolic loop and site C is located in the 
C-Terminal, or the tail of the pump (Ficarella et al, 
2007).  When the cells were perfused with calcium 
chloride, mutations at Site A and Site C caused a 
dramatic decrease in the intake of Ca
2+
 ions (Ficarella 
et al, 2007).  Thus, it can be deduced that PMCA2 
plays a critical role in the intake of Ca
2+
 ions, which 
implies that a decrease in the ion concentration leads to 
a significant loss of hearing. 
 
 
  
 38 
 
 
Figure 2. Effects of genetic mutations. This diagram illustrates the four specific genes studied and the effects of  their mutation.  Each 
gene mutation causes malfunctions of a particular area within the inner ear.  Alterations of any one of these four genes can lead to a defect 
in specific proteins.  These proteins then lead to the deformation of cell structure, resulting in nonsyndromic deafness. 
 
Expressway to Deafness 
Recent research and experimentation have shown that 
malfunction of the PMCA2 leads to a decrease in Ca
2+
 
entering the cell, significant imbalance, and a loss of 
hearing. However, if PMCA2 gene is functioning 
normally, then a Ca
2+
 influx causes the vesicle to bind 
to the presynaptic membrane and to release the 
neurotransmitter.   
At this point, the electrical signal has 
departed the cell.  The sensory cells need to prepare 
for the next signal by returning to resting potential.  The 
cell does this by forming ion channels that remove the 
K
+
 buildup.  KCNQ4 is essential for the formation of 
these types of ion channels. 
 
KCNQ4 
 
The Beginning of the Roadtrip: Background on Voltage-
Gated Potassium Channels 
In the mid 1990’s, only two genes were known to 
encode K
+
 channels, KCNQ1 and KCNE1 (Kubisch et 
al, 1999).  KCNQ1 is a voltage-gated K
+
 channel with 
six transmembrane domains, found in the cochlea and 
other locations, including the heart and brain cells. 
KCNQ1 helps in the secretion of K
+
 into the endolymph 
from the stria vascularis.  KCNE1 further enhances the 
currents from KCNQ1.  Mutations in either protein halts 
the K
+
 recirculation (Beisel et al., 2005) and can lead to 
a disease known as long QT syndrome.  This disease is 
characterized by arrhythmias due to repolarization 
anomalies of the cardiac action potential, and can lead 
to sudden death (Kubisch et al, 1999).  Two other 
genes, KCNQ2 and KCNQ3, also create K
+
 channels, 
but are not specific to the ear.  Neonatal convulsions 
result from mutations in either of these proteins 
(Kubisch et al., 1999).  Recently, the KCNQ protein 
family has been found in many more electrically 
excitable tissues, including skeletal muscle and the 
retina (Beisel et al., 2005).   
 
An Unknown Route: The Identification of KCNQ4 
In 1999, a new gene was discovered that belonged in 
the KCNQ family of K
+
 channels.  This gene, KCNQ4, 
was specifically found in the outer hair cells of the 
cochlea and was mapped on the DFNA2 locus (Kubisch 
et al, 1999).  This area also encodes many other 
proteins, which, when mutated, cause diseases 
associated with dominant progressive hearing loss 
(Figure 2).  Therefore, KCNQ4 was a likely candidate 
for autosomal dominant high-frequency hearing loss.   
 
A Well-Oiled Vehicle: The Function of KCNQ4 
In non-mutated genes, KCNQ4 forms tetramers in 
which four proteins join to form the pore.  In each of 
these proteins, a region called the P-loop forms the 
narrowest part.  This narrow section allows the pore to 
be selective for K
+
 ions (Kubisch et al, 1999).  After the 
influx of calcium, the voltage-gated KCNQ4 channels 
open to allow the passive diffusion of K
+
 out into the 
perilymph, repolarizing the cell (Wangemann, 2006).  
This K
+
 current out of the hair cells is then picked up by 
the surrounding cells and recycled back into the 
endolymph.   
 
Road Construction Ahead: A Mutation in the Genetic 
Sequence 
In a French family with high-frequency deafness, a 
mutation (G285S) was found in the sequence for the P-
loop for the K
+
 pore (Kubisch et al, 1999).  The normal 
amino acid sequence contains glycine, which is highly 
conserved in all the KCNQ proteins (Kubisch et al., 
1999).  However, the mutant gene sequence had a 
change of one specific nucleotide, replacing guanine 
with adenine.  From this, the glycine amino acid is 
converted to a serine (Kubisch et al, 1999).  This 
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mutation disrupts the selectivity of the pore, and causes 
it to function improperly (figure 1D).  When the wild-type 
(WT) and mutant proteins were expressed in Xenopus 
oocytes, the K
+
 current out of the cell drastically 
decreased in mutant channels compared to the WT 
channels (Kubisch et al, 1999).  From these results, it 
was believed that KCNQ4 was important in the removal 
of K
+
 for keeping the electrical excitation conditions (the 
concentration of K
+
 in the endolymph) constant for the 
next round of stimulation.   
 
Triple A: Developing the Mouse Model 
At that time, the only models available to study 
channels were frog eggs, which are very different from 
sensory transduction cells.  Therefore, an advanced 
model was needed to better understand the function of 
the proteins on the OHC, and a mouse model was 
created.  Researchers were able to produce knockout 
mice (KO) which deleted the P-loop region, and knock-
in mice (KI) that had the specific mutation in the 
genome (dominant negative allele).  It was found that 
the knockout and dominant negative allele mice had the 
same reduction for the K
+
 current out of the cells at 3 
weeks of age.  Over a longer period of time, both types 
of mice had the OHC completely degraded (Kharkovets 
et al., 2006).  By missing an essential part of the 
hearing pathway (the OHC), the signal was not able to 
be passed on, and thus deafness occurred.  Currently, 
it is believed that KCNQ4 is essential in the OHC to 
remove the K
+
 ions in order to repolarize the cell, not to 
replenish the endolymph K
+
 concentration as originally 
thought.   
A mutation in the KCNQ4 gene leads to an 
amino acid change in the K
+
 pore and results in a 
nonselective ion channel (Figure 1D).  The cell is 
unable to repolarize, and degration of the cell occurs 
over time.  If the KCNQ4 gene is normal, the K
+
 
channel is able to return the cell to resting potential, 
and the next signal can be generated. 
 Another important part in generating the next 
signal is the recycling of K
+
.  While returning to resting 
potential, the hair cells excrete the K
+
 ions into the 
perilymph.  However, the ions must go back to the 
endolymph to be used in a future action potential.  The 
use of intercellular connections made by connexins is 
critical for this movement. 
  
Connexin 26 
 
Conjunction Junction, What’s Your Function: Location 
and Normal Function of Connexin 26 
Connexin 26, a gap junction protein found in the 
cochlea and epidermis, is created with instructions 
found on the GJB2 gene.  More specifically, connexin 
26 is found in the stria vascularis, the spiral limbus, and 
the supporting cells found in the cochlea (Figure 1A).                               
Connexins are a family of transmembrane proteins that 
form channels allowing for rapid transport of ions and 
small molecules.  Intercellular communication relies on 
gap junctions created by proteins like connexin 26.  
Channels formed with connexin 26 are largely involved 
in the transport of potassium and other small molecules 
(Casalotti et al., 1999).  Potassium is required for the 
transformation of sound waves into electrical impulses 
that can be sent from cell to cell.  The importance of 
potassium in hearing and influence of connexin 26 on 
potassium levels has lead researchers to explore the 
link between connexin 26 and deafness. 
At least four other connexins are also found 
in the ear, some of which are also associated with 
deafness.  Connexin 26 mutations, however, are the 
most prominent cause of nonsyndromic forms of 
deafness.  Deafness related to connexin 26 occurs in 
an autosomal recessive manner (Ahmad et al., 2005).  
Different mutations in the GJB2 gene lead to various 
problems involving function, but the outcome is the 
same in all cases: profound deafness.  While 
researchers know that GJB2 mutations lead to 
deafness, the way in which GJB2 mutations affect 
hearing remains largely unknown.  Several factors have 
made studying GJB2 mutations difficult. The biggest 
hindrance to research is the fact that GJB2 deficient 
mice are embryonically lethal (Aoki et al., 2003).  Thus, 
transgenic mice are the key to understanding deafness 
as caused by GJB2 mutations.  
 
Potholes in the Road: The Effects of Mutations 
Mutation of the GJB2 gene was found to generate 
significant changes in the inner ear of mutant mice.  
Hearing development in mice differs from that of 
humans, in that humans have fully developed hearing 
capabilities at birth, while mice are not fully matured in 
this area until about two weeks after birth (Aoki et al., 
2003).  Examination of the inner ear of the genetically 
mutated mice at two weeks revealed that the tunnel of 
Corti had collapsed and that sensory hair cells were 
deformed.  By seven weeks the organ of Corti had 
begun to degenerate as had the spiral ganglia and hair 
cells. However, components responsible for the 
generation of endocochlear potential, such as the spiral 
ligament and stria vascularis, showed no alteration 
(Aoki et al., 2003).   
The sustained structural integrity of these 
components suggests that the conditions within the 
endolymph have been maintained.  This led 
researchers to believe that the epithelial gap junction 
system as the malfunctioning system.  Disruption of the 
epithelial gap junction system hinders potassium intake 
which is necessary for transmission of signals by the 
hair cells (Aoki et al., 2003).  
In addition to destroying or damaging many of the 
necessary inner ear components, various GJB2 
mutations have been seen to impair intercellular 
coupling.  Gap junctions are thought to be involved in 
the circulation of potassium between the fluids of the 
inner ear (Ahmad et al., 2005).  Thus, understanding 
how and where mutations interfere with the formation of 
gap junctions is an important step in moving towards 
treatment.  Connexin 26 is comprised of two 
transmembrane domains and extracellular loops.  
Alterations in these respective areas produced different 
results (Casalotti et al, 1999).  Mutations in the 
transmembrane domains prevented oligomerization of 
proteins, thereby hindering the formation of connexons. 
Other mutations disrupt the alignment of the connexons 
or the structure of the gap.  Problems with connexons 
or their formations interfere with intercellular coupling 
(Figure 2).  Certain mutations affect the flow of 
biochemicals while leaving the flow of ions unharmed 
(Ahmad, 2005). 
 
Around the Bend: Future Studies in Deafness 
 
Deafness is a pathological condition that causes partial 
or complete loss of hearing.  Many genes responsible 
for this disease were identified and four specific genes 
were investigated.  Although current studies on 
deafness have helped to fill some of the gaps in 
knowledge, the precise mechanisms involved in hearing 
are still not completely understood.  The inner ear is a 
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complex organ involving many cells with varying 
functions.  While individual cells and their components 
seem like small tasks to investigate, their effects on the 
system as a whole are much more difficult to 
understand.   
This review examined four genes, but over 
thirty different genes have been linked to deafness.  
The complexity of the four genes reviewed helps 
illustrate how complicated the picture truly is.  Mutations 
on any of these thirty genes lead to profound changes 
that hinder other processes as well, leading to the 
degradation of sound perception.   
Despite the fact that recent research has 
discovered much about these four genes, many 
questions still remain.  The rate step of the ATP 
hydrolysis mechanism and its effects on hearing have 
many gaps that need to be explored to truly understand 
the role of Myosin VI in the auditory system.  Additional 
studies could examine the overall understanding of the 
mechanism underlying the histopathology of the organ 
of Corti and how PMCA2 is dependent on other ion 
channels.  It is still not clear how the build up of K
+
 in 
the hair cells leads to the degradation.   
Further understanding of how and why the 
cell responds to the high K
+
 concentration is key to 
understanding another step in deafness.  Also, the 
mouse model created in recent years can provide a 
useful tool for testing drugs (like K
+
 channel openers) to 
slow the progress of deafness (Kharkovets et al., 2006).  
One recent study illustrated how Connexin30-linked 
deafness could be combated by increasing the 
expression of Connexin 26 (Ahmad, 2007).  Future 
studies could reverse this experiment and explore 
correcting Connexin 26-linked deafness through the 
use of other connexins, such as connexin30. 
 
The Final Destination 
 
Many genes play a critical role in auditory system 
function.  The four genes described each play a 
different role in hearing, but share a common theme.  
Mutation of each gene causes a significant disruption of 
hearing (Figure 2).  Myosin VI gene mutations affect the 
mobility of proteins, which in turn affects the stability of 
the stereocilia.  Mutations in the PMCA2 pump cause a 
significant loss of hearing, imbalance, and a dramatic 
decrease in calcium’s entrance into the cell.  KCNQ4 
mutations reduce the ability to repolarize the hair cells 
resulting in the cells degradation.  Connexin 26 is 
prevalent throughout the inner ear and plays a vital role 
in the formation of gap junctions, which allow for the 
transport of potassium ions.    While each gene 
performs a very different function, they all play a critical 
role in the auditory system. 
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